• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心包积液和心脏压塞的病理生理学及治疗新方法。

Pericardial Effusion and Cardiac Tamponade Pathophysiology and New Approaches to Treatment.

机构信息

Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center and Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.

出版信息

Curr Cardiol Rep. 2023 Sep;25(9):1003-1014. doi: 10.1007/s11886-023-01920-8. Epub 2023 Jul 29.

DOI:10.1007/s11886-023-01920-8
PMID:37515704
Abstract

PURPOSE OF REVIEW

The objective of this manuscript is to examine up-to-date approaches to the diagnosis and treatment of pericardial effusions and cardiac tamponade.

RECENT FINDINGS

Recent recommendations from the American Society of Echocardiography and the European Society of Cardiology have improved our management of the patient with pericardial effusion and cardiac tamponade, but significant knowledge gaps remain. Novel diagnostic and triage strategies have been suggested, and recent information have improved our facility to assess the presence and size of a pericardial effusion, assess its hemodynamic impact, and determine its cause. Despite these recent findings, there is a scarcity of evidence-based data to direct the management of pericardial effusion and cardiac tamponade. While the first-line function of echocardiography in managing these disorders is undisputed, there are increasingly niche functions for multimodality imaging.

摘要

目的综述

本文旨在探讨心包积液和心脏压塞的最新诊断和治疗方法。

最近发现

美国超声心动图学会和欧洲心脏病学会的最新建议改善了我们对心包积液和心脏压塞患者的管理,但仍存在重大知识空白。提出了新的诊断和分诊策略,最近的信息提高了我们评估心包积液存在和大小、评估其血流动力学影响以及确定其病因的能力。尽管有这些最新发现,但指导心包积液和心脏压塞管理的循证数据仍然匮乏。虽然超声心动图在管理这些疾病方面的一线作用是毋庸置疑的,但多模式成像的应用范围越来越广。

相似文献

1
Pericardial Effusion and Cardiac Tamponade Pathophysiology and New Approaches to Treatment.心包积液和心脏压塞的病理生理学及治疗新方法。
Curr Cardiol Rep. 2023 Sep;25(9):1003-1014. doi: 10.1007/s11886-023-01920-8. Epub 2023 Jul 29.
2
Pericardial Effusion and Cardiac Tamponade in the New Millennium.新千年的心包积液与心脏压塞
Curr Cardiol Rep. 2017 Jul;19(7):57. doi: 10.1007/s11886-017-0867-5.
3
Pericardial effusion with cardiac tamponade caused by a central venous catheter in a very low birth weight infant.极低出生体重儿因中心静脉导管导致的心包积液伴心脏压塞。
Pan Afr Med J. 2016 Sep 20;25:13. doi: 10.11604/pamj.2016.25.13.8731. eCollection 2016.
4
Pericardial tamponade: A comprehensive emergency medicine and echocardiography review.心包填塞:综合急救医学与超声心动图复习
Am J Emerg Med. 2022 Aug;58:159-174. doi: 10.1016/j.ajem.2022.05.001. Epub 2022 May 6.
5
Diagnostic value of echocardiography in cardiac tamponade.超声心动图在心脏压塞中的诊断价值。
Herz. 2000 Dec;25(8):734-40. doi: 10.1007/pl00001991.
6
Pericardial Effusions: Causes, Diagnosis, and Management.心包积液:病因、诊断与处理
Prog Cardiovasc Dis. 2017 Jan-Feb;59(4):380-388. doi: 10.1016/j.pcad.2016.12.009. Epub 2017 Jan 4.
7
Mediastinal effusion due to pericardiocentesis with cardiac tamponade: a case report.心包穿刺导致的心包积液压迫:病例报告。
BMC Anesthesiol. 2021 Jun 16;21(1):172. doi: 10.1186/s12871-021-01385-8.
8
New Approaches to Management of Pericardial Effusions.心包积液管理的新方法
Curr Cardiol Rep. 2021 Jul 1;23(8):106. doi: 10.1007/s11886-021-01539-7.
9
Pericardial tamponade in a 21-year-old female patient.一名21岁女性患者出现心包填塞。
Heart. 2019 Nov;105(21):1634-1681. doi: 10.1136/heartjnl-2019-315738. Epub 2019 Aug 29.
10
A new scoring system for the triage of cardiac tamponade.一种用于心脏压塞分诊的新评分系统。
Expert Rev Cardiovasc Ther. 2015 Mar;13(3):237-8. doi: 10.1586/14779072.2015.1007127. Epub 2015 Feb 15.

引用本文的文献

1
A Case of Pericarditis With Pericardial Effusion Due to Lyme Disease.一例由莱姆病引起的伴有心包积液的心包炎病例。
Cureus. 2025 Jul 7;17(7):e87476. doi: 10.7759/cureus.87476. eCollection 2025 Jul.

本文引用的文献

1
Cholesterol Pericarditis.胆固醇性心包炎
JACC Case Rep. 2022 Jul 6;4(13):808-813. doi: 10.1016/j.jaccas.2022.04.001.
2
Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients.718365 例 COVID-19 患者中心肌炎和心包炎的患病率及临床结局。
Eur J Clin Invest. 2021 Nov;51(11):e13679. doi: 10.1111/eci.13679. Epub 2021 Sep 18.
3
New Approaches to Management of Pericardial Effusions.心包积液管理的新方法
Curr Cardiol Rep. 2021 Jul 1;23(8):106. doi: 10.1007/s11886-021-01539-7.
4
Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion.抗炎药物对恶性心包积液患者临床结局的影响。
J Am Coll Cardiol. 2020 Sep 29;76(13):1551-1561. doi: 10.1016/j.jacc.2020.08.003.
5
Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions.慢性、大量、血流动力学无显著意义、C 反应蛋白阴性、特发性心包积液患者心包引流的长期转归。
Am J Cardiol. 2020 Jul 1;126:89-93. doi: 10.1016/j.amjcard.2020.03.035. Epub 2020 Apr 8.
6
Clinical Utility of [F]FDG-PET /CT in Pericardial Disease.[F]FDG-PET/CT 在心包疾病中的临床应用。
Curr Cardiol Rep. 2019 Aug 2;21(9):107. doi: 10.1007/s11886-019-1193-x.
7
Is pericardial effusion a negative prognostic marker? Meta-analysis of outcomes of pericardial effusion.心包积液是否是预后不良的标志物?心包积液结局的荟萃分析。
J Cardiovasc Med (Hagerstown). 2019 Jan;20(1):39-45. doi: 10.2459/JCM.0000000000000720.
8
Outcomes of idiopathic chronic large pericardial effusion.特发性慢性大量心包积液的转归。
Heart. 2019 Mar;105(6):477-481. doi: 10.1136/heartjnl-2018-313532. Epub 2018 Oct 1.
9
Pericardial Effusion and Cardiac Tamponade in the New Millennium.新千年的心包积液与心脏压塞
Curr Cardiol Rep. 2017 Jul;19(7):57. doi: 10.1007/s11886-017-0867-5.
10
Colchicine for Post-Operative Pericardial Effusion: Preliminary Results of the POPE-2 Study.秋水仙碱用于术后心包积液:POPE-2研究的初步结果
J Am Coll Cardiol. 2015 Sep 8;66(10):1198-9. doi: 10.1016/j.jacc.2015.05.078.